鞘内注射β-干扰素治疗多发性硬化症的双盲研究：临床及实验室结果
Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results.
作者信息
Milanese C, Salmaggi A, La Mantia L, Campi A, Eoli M, Savoiardo M, Bianchi G, Nespolo A
机构信息
Department of Neurology, Istituto Neurologico C Besta, Milan, Italy.
出版信息
J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):554-7. doi: 10.1136/jnnp.53.7.554.
Abstract
Sixteen patients with clinically definite MS admitted to a double blind randomised controlled trial of intrathecal natural beta-IFN were followed for a mean of 22 months including the six month treatment period. Clinical response, evaluated in terms of relapse frequency and of progression rate, showed an increase in relapse rate in treated patients during the six month treatment period and, overall, no benefit in treated versus placebo patients. Serial evaluations were made of cerebrospinal fluid (CSF) cells, IgG, myelin basic protein and CSF and blood T-cell subsets. A rise in CSF IgG Index, MBP and DR+ cells in IFN-treated patients suggested an activation of intrathecal immune response in treated patients.
摘要
16名临床确诊为多发性硬化症的患者参加了一项鞘内注射天然β-干扰素的双盲随机对照试验，随访时间平均为22个月，包括6个月的治疗期。根据复发频率和进展速度评估的临床反应显示，在6个月的治疗期内，治疗组患者的复发率有所增加，总体而言，治疗组与安慰剂组患者相比并无益处。对脑脊液（CSF）细胞、免疫球蛋白G（IgG）、髓鞘碱性蛋白（MBP）以及脑脊液和血液中的T细胞亚群进行了系列评估。干扰素治疗组患者脑脊液中的IgG指数、MBP和DR+细胞升高，提示治疗组患者鞘内免疫反应被激活。
相似文献
1
Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results.鞘内注射β-干扰素治疗多发性硬化症的双盲研究：临床及实验室结果
J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):554-7. doi: 10.1136/jnnp.53.7.554.
2
Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis.
Mult Scler. 1998 Dec;4(6):475-9. doi: 10.1177/135245859800400603.
3
CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Acta Neurol Scand. 1992 Sep;86(3):291-7. doi: 10.1111/j.1600-0404.1992.tb05088.x.
4
Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis.多发性硬化症中的鞘内IgG合成及自身抗体分泌细胞
J Neuroimmunol. 2000 Aug 1;108(1-2):207-15. doi: 10.1016/s0165-5728(00)00292-7.
5
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity.多发性硬化症中的脑脊液T细胞亚群：与脑脊液髓鞘碱性蛋白及临床活动的关系
J Neurol. 1989 Sep;236(6):336-9. doi: 10.1007/BF00314375.
6
Three possible laboratory indexes of disease activity in multiple sclerosis.多发性硬化症疾病活动的三种可能的实验室指标。
Neurology. 1987 Mar;37(3):515-9. doi: 10.1212/wnl.37.3.515.
7
T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.来自多发性硬化症患者的T细胞可识别脑脊液中的免疫球蛋白G。
Mult Scler. 2003 Jun;9(3):228-34. doi: 10.1191/1352458503ms906oa.
8
Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.α干扰素与转移因子治疗多发性硬化症：一项双盲、安慰剂对照试验。澳大利亚多发性硬化症研究组
J Neurol Neurosurg Psychiatry. 1989 May;52(5):566-74. doi: 10.1136/jnnp.52.5.566.
9
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment.静脉注射合成肽MBP8298可延缓HLA II类定义的进行性多发性硬化症患者队列的疾病进展：一项为期24个月的双盲安慰剂对照临床试验及5年随访治疗的结果
Eur J Neurol. 2006 Aug;13(8):887-95. doi: 10.1111/j.1468-1331.2006.01533.x.
10
[Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].[脑脊液检查结果在多发性硬化症诊断中的应用]
Srp Arh Celok Lek. 1995 Jul-Aug;123(7-8):191-3.
引用本文的文献
1
Acetaminophen modulates the transcriptional response to recombinant interferon-beta.对乙酰氨基酚调节重组干扰素-β的转录反应。
PLoS One. 2010 Jun 9;5(6):e11031. doi: 10.1371/journal.pone.0011031.
2
Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.α干扰素和β干扰素可限制多瘤病毒JC在原代人胎儿神经胶质细胞中的复制：对进行性多灶性白质脑病治疗的意义。
J Infect Dis. 2007 Sep 1;196(5):712-8. doi: 10.1086/520518. Epub 2007 Jul 20.
3
Interferon in relapsing-remitting multiple sclerosis.干扰素在复发缓解型多发性硬化症中的应用
Cochrane Database Syst Rev. 2001;2001(4):CD002002. doi: 10.1002/14651858.CD002002.
4
Does a placebo-effect exist in clinical trials on multiple sclerosis? Review of the literature.在多发性硬化症的临床试验中是否存在安慰剂效应？文献综述。
Ital J Neurol Sci. 1996 Apr;17(2):135-9. doi: 10.1007/BF02000844.
5
Interferons in multiple sclerosis. A review of the evidence.干扰素与多发性硬化症。证据综述。
Drugs. 1992 Dec;44(6):946-62. doi: 10.2165/00003495-199244060-00004.
本文引用的文献
1
Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.重组人干扰素对小鼠自然杀伤细胞活性的体内外调节作用
Cancer Res. 1984 Feb;44(2):597-601.
2
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).评估多发性硬化症的神经功能损伤：扩展残疾状态量表（EDSS）
Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
3
Systemic alpha-interferon therapy of multiple sclerosis.多发性硬化症的全身α-干扰素治疗
Neurology. 1984 Oct;34(10):1273-9. doi: 10.1212/wnl.34.10.1273.
4
Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.γ干扰素对人细胞中HLA抗原及其mRNA合成的优先作用。
Nature. 1982 Oct 28;299(5886):833-6. doi: 10.1038/299833a0.
5
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients.多发性硬化症患者白细胞培养物中的干扰素产生及自然杀伤（NK）活性。
J Neurol Sci. 1983 Jul;60(1):137-50. doi: 10.1016/0022-510x(83)90133-8.
6
Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferon.前列腺素E对多发性硬化症及其他神经疾病患者外周血和脑脊液中自然杀伤细胞细胞毒性的调节作用。第1部分。前列腺素生成量、自然杀伤细胞与内源性干扰素之间的关联。
J Neuroimmunol. 1983 Jun;4(3):223-37. doi: 10.1016/0165-5728(83)90037-1.
7
Interferon responses of leukocytes in multiple sclerosis.
Neurology. 1981 May;31(5):561-6. doi: 10.1212/wnl.31.5.561.
8
Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.对多发性硬化症患者淋巴细胞产生干扰素及自然杀伤作用的研究。
Ann N Y Acad Sci. 1984;436:181-91. doi: 10.1111/j.1749-6632.1984.tb14789.x.
9
Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro.
J Clin Immunol. 1985 Nov;5(6):386-9. doi: 10.1007/BF00915335.
10
Zotero 插件